We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00285948
Recruitment Status : Completed
First Posted : February 2, 2006
Last Update Posted : February 18, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
To prospectively obtain data about the clinical and radiological results of the resurfacing technique as primary hip prosthesis in young active patients

Condition or disease Intervention/treatment
Indications for a Total Hip Prosthesis Device: Primary Birmingham hip resurfacing arthroplasty using a metal-on-metal couple

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient
Study Start Date : November 1998
Primary Completion Date : January 2009
Study Completion Date : January 2009
Arms and Interventions


Outcome Measures

Primary Outcome Measures :
  1. Clinical and radiological results

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Total hip prosthesis

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00285948


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent
More Information

Additional Information:
Responsible Party: René Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00285948     History of Changes
Other Study ID Numbers: 2004/339
First Posted: February 2, 2006    Key Record Dates
Last Update Posted: February 18, 2009
Last Verified: February 2009